Cold snaring biopsies to increase screening efficacy during endoscopic surveillance of patients at high risk of diffuse gastric cancer
Marie Lemoine Laroussinie, Mathieu Pioche, Laura Calavas, Tanguy Fenouil, Jean-Christophe Saurin, Arnaud Pasquer, Nicolas Benech

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Fig. 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHelicobacter pylori-related gastroenterology studies · Gastric Cancer Management and Outcomes · Wnt/β-catenin signaling in development and cancer
Diffuse gastric cancer (DGC) is a poorly differentiated adenocarcinoma of the stomach characterized by independent “signet-ring” cells that invade the gastric wall with mainly submucosal infiltration resulting in delayed diagnosis 1 . Mutations in the CDH1 gene, encoding E-cadherin, have been identified in families with multiple cases of gastric cancer, with a 50%–80% increased risk of DGC in carriers 2 . In cases with a proven constitutional CDH1 mutation, guidelines recommend prophylactic total gastrectomy between the ages of 20 and 30 years, or endoscopic surveillance if surgery is refused or postponed 3 .
Given the multiple possible localizations and frequency of small carcinomatous foci, a minimum of 30 biopsies divided into six zones using standard forceps is recommended 3 4 . However, multiple sampling of the gastric mucosa using conventional biopsy forceps still represents a limited surface area that can be analyzed. Increasing the size of the biopsy sample using cold snaring may increase diagnostic sensitivity.
We report here the case of a 33-year-old patient with regular endoscopic surveillance after identification of a CDH1 mutation in a familial context.
Gastroscopy and endoscopic ultrasound were performed, with no findings of macroscopic abnormalities, parietal thickening, or suspicious adenopathy ( Video 1 ). To increase the size of the tissue sampled for histological analysis, 24 cold snaring biopsies (6 upper fundus, 6 body, 6 lower body, and 6 antrum) were performed. Pathological analysis revealed a single focal area of independent cell adenocarcinoma in the chorion (pTis) seen only in one sample. A gastrectomy was then performed, with a millimetric focal adenocarcinoma with signet-ring cells on the surgical specimens.
Gastric sampling using random cold snaring of the whole stomach with visualization of the corresponding resected area.Video 1
Histopathological analysis was improved, with the average size of biopsy fragments being significantly larger with cold snaring than with standard forceps, and with a reduction in crush artifacts ( Fig. 1 ).
Histopathological characterization (hematoxylin and eosin) of specimens from patients followed endoscopically due to familial predisposition for CDH1 mutation-related gastric adenocarcinoma. a Cold snaring biopsy. b Standard forceps biopsy. c The mean size of biopsy fragment was significantly increased with cold snaring (patient A) compared with standard forceps (patients B and C), based on the examination of three patients with 18, 30, and 28 fragments biopsied, respectively (one-way analysis of variance with Dunnett’s multiple comparisons, **** P < 0.0001; GraphPad Prism v10.0.0). d Cold snaring sample: the crushing artifacts often observed with standard forceps were not seen in the cold snaring biopsies (×20 magnification; e ×40 magnification).
In conclusion, this case suggests that large samples obtained with cold snaring could potentially decrease the focal adenocarcinoma miss rate in CDH1 mutation carriers.
Endoscopy_UCTN_Code_TTT_1AO_2AC
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Ikoma N Agnes A Chen H-C Linitis plastica: a distinct type of gastric cancer J Gastrointest Surg 2020241018102510.1007/s 11605-019-04422-731754987 · doi ↗ · pubmed ↗
- 2Hansford S Kaurah P Li-Chang H Hereditary diffuse gastric cancer syndrome: CDH 1 mutations and beyond JAMA Oncol 20151233210.1001/jamaoncol.2014.16826182300 · doi ↗ · pubmed ↗
- 3Fitzgerald RC Hardwick R Huntsman D Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research J Med Genet 20104743644410.1136/jmg.2009.07423720591882 PMC 2991043 · doi ↗ · pubmed ↗
- 4van der Post RS Vogelaar IP Carneiro F Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH 1 mutation carriers J Med Genet 20155236137425979631 10.1136/jmedgenet-2015-103094 PMC 4453626 · doi ↗ · pubmed ↗
